Showing results (141-150 of 167) with videos related to
Sort By:
Pageof 17
JCO Clinical Cancer Informatics|October 28, 2022
Evaluation of the Clinical Utility of the Bone Metastases Ensemble Trees for Survival Decision Support Platform (BMETS-DSP): A Case-Based Pilot AssessmentSara R Alcorn, Anna W LaVigne, Christen R Elledge, et al.Urologic Oncology|March 20, 2018
Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapyLuke C Peng, Amol K Narang, Carol Gergis, et al.Biorxiv : the Preprint Server for Biology|October 31, 2023
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.International Journal of Radiation Oncology, Biology, Physics|August 18, 2020
Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate CancerMatthew P Deek, Kekoa Taparra, Dyda Dao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomyAndrew J Stephenson, Peter T Scardino, Michael W Kattan, et al.Nature Communications|August 28, 2024
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancerMindy K Graham, Rulin Wang, Roshan Chikarmane, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2018
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and ImmunotherapyAriel E Marciscano, Ali Ghasemzadeh, Thomas R Nirschl, et al.The Lancet. Oncology|June 1, 2026
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trialTheodore L DeWeese, Andrea Manzanera, John Sylvester, et al.Urology|August 2, 2008
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancerEdouard J Trabulsi, Richard K Valicenti, Alexandra L Hanlon, et al.Advances in Radiation Oncology|May 27, 2024
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate CancerPhilip Sutera, Matthew P Deek, Rebecca A Deek, et al.Pageof 17